Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kivalo Inc.

www.kivalo.com

Latest From Kivalo Inc.

Kivalo Inc.

For children, the elderly, and other diabetics who have difficulty in complying with glucose monitoring regimes, Kivalo Inc. offers hope in the form of technology that automatically reads glucose levels from any commercially available monitor, then wirelessly transmits that data to parents or caregivers to notify them of an impending crisis.
Medical Device

Glucose Monitoring Systems: The State of the Art

The glucose meter market is dominated by established big-company players. They all have a variety of meters to suit the lifestyles of different types of patients, from simple finger-stick lancets to less painful alternate site meters to elaborate systems that capture, store, plot, and transmit data and display dietary information. Most are also aiming their R&D at developing minimally invasive or percutaneous continuous glucose monitoring systems. The companies profiled in this issue each have a product development strategy designed to address the limitations of current technologies, and are directing their efforts at some of the many niches in the glucose testing market.
Medical Device

Start-Up Previews (3/03)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Glucose Monitoring Start-Ups, features profiles of Advanced BioSensors Inc., Kivalo Inc., M-Biotech Inc. and Pelikan Technologies Inc. Plus these Start-Ups across Health Care: Auxilium Pharmaceuticals Inc., GenPath Pharmaceuticals Inc. and Newron Pharmaceuticals SPA.
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Glucose Testing
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Kivalo Inc.
  • Senior Management
  • J. Llyod Breedlove, Pres. & CEO
  • Contact Info
  • Kivalo Inc.
    Phone: (704) 663-7367
    531 Hermitage Court
    Ste. 100
    Charlotte, NC 28207
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register